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Purpose: The objective was to assess whether dyspnea, peripheral muscle strength and the level 
of physical activity are correlated with life-space mobility of older adults with COPD.
Patients and methods: Sixty patients over 60 years of age (40 in the COPD group and 20 in 
the control group) were included. All patients were evaluated for lung function (spirometry), life-
space mobility (University of Alabama at Birmingham Study of Aging Life-Space Assessment), 
dyspnea severity (Modified Dyspnea Index), peripheral muscle strength (handgrip dynamometer), 
level of physical activity and number of daily steps (accelerometry). Groups were compared 
using unpaired t-test. Pearson’s correlation was used to test the association between variables.
Results: Life-space mobility (60.41±16.93 vs 71.07±16.28 points), dyspnea (8 [7–9] vs 
11 [10–11] points), peripheral muscle strength (75.16±14.89 vs 75.50±15.13 mmHg), num-
ber of daily steps (4,865.4±2,193.3 vs 6,146.8±2,376.4 steps), and time spent in moderate to 
vigorous activity (197.27±146.47 vs 280.05±168.95 minutes) were lower among COPD group 
compared to control group (p,0.05). The difference was associated with the lower mobility of 
COPD group in the neighborhood.
Conclusion: Life-space mobility is decreased in young-old adults with COPD, especially at 
the neighborhood level. This impairment is associated to higher dyspnea, peripheral muscle 
weakness and the reduced level of physical activity.
Keywords: COPD, elderly, mobility limitation, dyspnea, muscular weakness
Introduction
COPD is the fourth leading cause of death worldwide and impairs the respiratory, 
musculoskeletal and psychological systems as well as social skills.1,2 These disorders 
are associated with functional disability and low health-related quality of life.1 
Progressive functional disability is commonly observed in older adults3 and leads to 
the need for help to carry out the activities of daily living (ADL).4 This functional 
dependence can occur early in older adults with COPD due to dyspnea, sarcopenia 
and low level of physical activity often related to the respiratory disorder.5
Mobility is highly related to health state, autonomy, independence, quality of life 
and need for care, especially among older adults. These factors must be considered 
in the evaluation of the older population to develop strategies for prevention and 
treatment of health problems.6 Life-space mobility refers precisely to the capacity, 
frequency and independence with which individual moves within the house, around 
the neighborhood and in other cities.7 Mobility can be affected by environmental, 
cognitive and physical factors, and the loss of life-space mobility among older adults 
appears to lead to worse quality of life,8 social isolation,9 symptoms of depression10 
and, possibly, physical inactivity. The association between chronic diseases and 
limited life-space mobility has been demonstrated among older patients with kidney 
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disease,11 fecal incontinence12 and stroke sequelae,13 but it 
has never been evaluated in the case of older patients with 
chronic respiratory diseases.
Physical inactivity is an important predictor of mortality 
in healthy older adults and also in patients with chronic 
diseases.14,15 Most COPD patients do not follow the current 
minimum recommendations for physical activity and have 
lower level of physical activity than healthy individuals.16,17 
Daily symptoms such as dyspnea and fatigue17 as well as envi-
ronmental and sociodemographic factors,18 exacerbations19 
and comorbidities20 influence the low levels of physical 
activity among these patients. The level of physical 
activity in COPD individuals can be evaluated through 
questionnaires.21 Questionnaires are low cost and easy to 
apply. They are generally used in epidemiological studies 
and large clinical trials.21 A variety of questionnaires have 
been designed to obtain data on different aspects of daily 
physical activity, including its intensity, type, quantity and 
limitations to perform ADL.21 Another way to assess the level 
of physical activity is the application of motion sensors,22 
such as accelerometers. These provide more accurate, 
individualized and detailed information about body move-
ments than questionnaires.21 However, accelerometers have 
some disadvantages; accelerometers are high cost needing 
technical expertise to manipulate and a “software” to analyze 
the obtained data.21 Furthermore, a general concern about 
motion sensors is the collaboration of the evaluated indi-
vidual. For example, such individual should remember to 
put on and properly place the device.23
Low levels of physical activity in COPD older adults are 
related to higher risk of hospital readmission24 and lower 
survival.25 Thus, given the close relationship between the 
levels of physical activity and health, their assessment is very 
important.26 Considering that reduced life-space mobility can 
affect the older adults’ quality of life and level of indepen-
dence more directly than physical inactivity, understanding 
the impact of COPD and the existence of any relationship 
between modifiable factors in the level of life-space mobility 
is necessary. The aim of this study was to assess whether 
dyspnea and peripheral muscle strength affect life-space 




This controlled cross-sectional study was conducted at 
Pneumology Service, Conjunto Hospitalar do Mandaqui, 
Brazil. Approval for the study was obtained from the Ethics 
Committee of the Universidade Cidade de São Paulo 
(CAAE: 29380314.0.0000.0064) and the Ethics Committee 
of the Conjunto Hospitalar do Mandaqui (CAAE: 
29380314.0.3001.5551), and all patients signed an informed 
consent form. Forty COPD patients out of 90 selected indi-
viduals were included in the respiratory diseases outpatient 
clinic. Other 20 healthy patients with corresponding age 
(control group) were included, in accordance with the calcu-
lated sample size, considering an expected effect size of 0.8, 
80% of power and alpha of 5%, with allocation of 2:1. All 
eligible participants were older adults over 60 years of age, 
according to the United Nations definition for older persons 
from developing countries,27–29 had no musculoskeletal or 
cognitive limitations that could interfere in the assessments 
and had not participated in regular physical activity in the 
last 6 months. The inclusion criteria for the COPD group 
were: monitoring in the Pulmonology Outpatient Clinic of 
the Conjunto Hospitalar do Mandaqui for at least 6 months, 
forced expiratory volume in the first second/forced vital 
capacity (FEV
1
/FVC) ,70% predicted after bronchodilator1 
and absence of heart disease or any other non-pulmonary 
cause of respiratory symptoms certified by the doctor. 
Inclusion criteria for the control group were: absence of 
respiratory symptoms or medical diagnosis of any chronic 
pulmonary disease, no history of smoking and lack of spiro-
metric changes. Exclusion criteria for both groups were: 
inability to complete all assessments, use of accelerometer 
for less than 3 consecutive days30 and modification of the 
clinical condition (hospitalization, emergency room visit or 
use of new medication) during the evaluation period.
Procedures
Patients included in the study and allocated in the COPD 
and control groups received detailed explanations on how to 
perform each procedure. After this, they were evaluated for 
clinical and anthropometric history, lung function, life-space 
mobility, dyspnea severity and peripheral muscle strength. 
After all assessments, which took 30 minutes on average, 
an accelerometer was fixed to the waist of the patient and 
removed after 1 week.
Measurements
Clinical and anthropometric measurements
Height and weight were measured according to National 
Institute of Health, Heart, Lung and Blood guidelines.31 
Information on other diseases, smoking, alcohol consump-
tion, respiratory symptoms (cough, expectoration, wheezing 
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life-space mobility in young-old with COPD
the patients.1 COPD severity was defined according to Global 
Initiative for Chronic Obstructive Lung Disease (GOLD) 
2017 guidelines.1
Pulmonary function
Simple spirometry was performed according to the American 
Thoracic Society/European Respiratory Society consensus 
criteria.32 FEV
1
, FVC and forced expiratory flow at the 
moment between 25% and 75% of the curve (FEF
25%–75%
) 
were analyzed in absolute values and in the reference values 
previously described for the Brazilian population.33
life-space mobility
The University of Alabama at Birmingham Study of Aging 
Life-Space Assessment7,34 questionnaire, culturally adapted 
to the Brazilian population, was used. This questionnaire 
consists of questions on five levels of spaces visited by the 
older adult in the 4 weeks prior to the assessment, including 
the following items: life-space level (sleeping room, internal 
housing area, external housing area, neighborhood, within the 
city and other cities), frequency (less than 1 time per week, 
1–3 times a week, 4–6 times a week or daily) and indepen-
dence (personal assistance, equipment assistance, without 
assistance) (Table S1).6,7 The score ranges from 0 to 120 and 
is obtained by combining the scores in each life-space level. 
Higher scores indicate greater life-space mobility.7
severity of dyspnea
The “Modified Dyspnea Index” (MDI) questionnaire adapted 
to Brazilian Portuguese35 was used. The MDI is an instru-
ment composed of three components: functional impairment, 
magnitude of the task and magnitude of the effort. The total 
score ranges from 0 to 12, as a result of the sum of scores 
(from zero to four) of each MDI component. The lower the 
score, the more severe the dyspnea.35
Peripheral muscle strength
A “handgrip” dynamometer was used. The measurement 
was performed with the dominant hand of the evaluated 
individual, respecting the protocol recommended by the 
American Association of Hand Therapists.36 The mean of 
the three measurements was used37 in its absolute value 
and in the reference value previously described for the 
Brazilian population.38
The level of physical activity and the number of 
daily steps
The accelerometer was used for 24 hours on 7 consecutive 
days. Accelerometers were installed in the waist of the patient 
using elastic straps.39 The collected values were adjusted 
for age, weight, height, gender and race. The mean of the 
values collected during 7 days of the following variables 
were analyzed: number of daily steps; percentage of daily 
time in sedentary, light, moderate and vigorous activity; and 
moderate-to-vigorous physical activity (MVPA).
statistical analysis
After descriptive analysis and the Kolmogorov–Smirnov 
normality test, the groups were compared using the unpaired 
t-test or Mann–Whitney tests to observe the initial homoge-
neity of groups and test the primary objective. The Pearson 
correlation coefficient was used to test the relationship 
between mobility in the COPD group and dyspnea severity, 
peripheral muscle strength and physical activity level. We 
consider the correlation weak when r=0.10 to 0.29, moder-
ate when r=0.30 to 0.49 and strong when r=0.50 to 1.40 The 
level of significance was set at 5%.
Results
Demographic comparison and initial 
clinical situation
Out of the 90 eligible patients, sixty adults over 60 years of 
age were included in the study; 40 were in the COPD group 
(29 GOLD II, 10 GOLD III and 1 GOLD IV) and 20 in 
the control group. The other 30 eligible patients did not 
agree to participate in the study due to the need to use the 
accelerometer. The two groups were similar in gender, age, 
body mass index, comorbidities, alcohol consumption and 
number of retirees. The mean age of participants in both groups 
classifies them as young-old adults.41 As expected, respira-
tory symptoms and spirometric variables were altered in the 
COPD group compared to the control group (Table 1).
Mobility, dyspnea, peripheral strength and 
level of physical activity
Results of overall mobility, dyspnea severity, mean percent-
age of time spent in moderate-intensity activity, MVPA and 
number of daily steps were different between the groups 
(Table 2). The significant difference found in mobility 
between the groups showed statistical power of 83% 
with p,0.05.
life-space mobility
Groups differed only in the total score (p=0.02; test 
power =0.83) and in the score of life-space level 3 (p=0.03; 
test power =0.79), which refers to displacement to places in 

















































































Powered by TCPDF (www.tcpdf.org)
                               1 / 1





Correlation between mobility and 
dyspnea, peripheral strength and 
accelerometry
Moderate and positive correlations were observed between 
mobility, assessed through the University of Alabama 
at Birmingham Study of Aging Life-Space Assessment 
questionnaire in COPD older adults, and the average per-
centage of time spent in moderate-intensity activity (r=0.40; 
p=0.01), number of daily steps (r=0.43; p=0.01), MVPA 
(r=0.43; p=0.01), dyspnea severity (r=0.44; p,0.001) and 
peripheral muscle strength (r=0.42; p,0.001) (Table 4).
Discussion
Our results showed that young-old adults with COPD had 
poor life-space mobility, especially to move within their 
neighborhood, when compared to young-old adults without 
lung disease. This impaired mobility is associated with 
dyspnea severity, peripheral muscle weakness and reduced 
physical activity level. The novelty of our study is the dem-
onstration of the association between all these variables, 
as well as their impact on one aspect not explored before 
such as life-space mobility, using an appropriate tool for 
this population.
The lowest level of mobility found among COPD older 
adults was associated with lower number of daily steps and 
less time spent in moderate-to-vigorous physical activities 
compared to healthy young-old adults. The ability to 
move within the community has never been evaluated in 
this population, but the present results are consistent with 
previous studies showing lower level of physical activ-
ity in COPD patients than in healthy individuals of same 
age and gender.16,42 It is known that this aspect may be 
associated with poor prognosis of the COPD43 and may 
cause adverse effects on these patients, particularly to their 
quality of life.44 The loss of quality of life can be even 
greater if we consider that the lowest score obtained by 
the young-old adults was related to visiting places in the 
neighborhood. Possibly, this decreased independence is 
one of the barriers to engaging in social activities,45 lead-
ing to a greater propensity to loneliness45 and difficulties 
to perform the ADL.16 Therefore, supplementary programs 
to treatment of COPD, such as pulmonary rehabilitation, 
should pay special attention to life-space mobility because 
this aspect better reflects the real life of this population than 
other variables traditionally measured, such as the 6-minute 
walk test.46 Furthermore, this would enhance other known 
benefits that aim to interfere in social interaction, depression 
and quality of life.47
Although it is believed that COPD patients with moder-
ate airway obstruction have few clinical consequences and, 
therefore, do not require rehabilitation, there is evidence 
that moderate airway obstruction is associated with reduced 
exercise capacity and level of physical activity in this 
population.16 Structural abnormalities such as pulmonary 







Male, n (%) 20 (50%) 13 (65%) 0.40
age, years 66.95±5.87 65.95±4.55 0.50
BMI, kg/m2 28.65±5.06 27.71±5.20 0.50
Comorbidities, n (%) 25 (62.5%) 15 (37.5%) 0.28
Diabetes, n (%) 12 (30%) 6 (30%) 0.76
sah, n (%) 22 (55%) 9 (45%) 0.64
ChF, n (%) 7 (17.5%) 5 (25%) 0.51
alcohol consumption, n (%) 7 (17.5%) 4 (20%) 1.00
retirees, n (%) 16 (40%) 12 (60%) 0.23
FeV1, % of the predicted 59.05±12.44 91.50±12.47 ,0.001
FVC, % of the predicted 63.12±10.06 91.25±15.56 ,0.001
FeF25%–75%, % of the predicted 46.67±10.49 85.95±17.11 ,0.001
Cough, n (%) 12 (30%) 0 (0%) ,0.001
expectoration, n (%) 12 (30%) 0 (0%) ,0.001
Wheezing, n (%) 21 (52.5%) 0 (0%) ,0.001
Dyspnea, n (%) 33 (82.5%) 0 (0%) ,0.001
Notes: Data are presented as mean ± standard deviation or absolute number 
(frequency). FeV1, FVC and FeF25%–75% are expressed as % of predicted.
33
Abbreviations: n, absolute number; BMI, body mass index; sah, systemic arterial 
hypertension; ChF, congestive heart failure; FeV1, forced expiratory volume in the 
first second; FVC, forced vital capacity; FEF25%–75% = forced expiratory flow at the 
moment between 25% and 75% of the curve, p-value of the t-test or chi-square test.
Table 2 Comparison of mobility, dyspnea severity, peripheral 
muscle strength and level of physical activity between groups (n=60)





Overall mobility, pts 60.41±16.93 71.07±16.28 0.02
severity of dyspnea, pts 8 (7–9) 11 (10–11) ,0.001
Peripheral strength, 
% of the predicted
75.16±14.89 75.50±15.13 0.94
sedentarism, % of the time 84±5 82±4 0.12
light activities, 
% of the time
13±4 14±3 0.26
Moderate activities, 
% of the time
1±1 2±1 0.04
Vigorous, % of the time 0.04±0.02 0.02±0.03 0.61
MVPa, minutes 197.27±146.47 280.05±168.95 0.04
Daily steps 4,865.4±2,193.3 6,146.8±2,376.4 0.04
Notes: Data are presented as mean ± standard deviation or absolute number 
(frequency) or median (interquartile range 25%–75%); peripheral force is expressed 
as % of the predicted;38 p-value of t-, chi-square and Mann–Whitney tests.
Abbreviations: n, absolute number; pts, points; % of the time = percentage of time 
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life-space mobility in young-old with COPD
air trapping, airway wall thickening, and vascular dys-
function48 contribute to increased ventilatory demand and 
compromise the ventilatory mechanics of patients with 
COPD.49 Thus, patients often restrict some more intense 
activities to avoid unpleasant symptoms, such as dyspnea.50 
Over time, this can lead to a spiral of worsening symp-
toms, deconditioning and exercise intolerance as patients 
become progressively more sedentary.50 In addition, car-
diocirculatory51 and musculoskeletal impairments52 have 
been reported in patients with mild to moderate COPD, as 
observed in the majority of young-old adults with COPD 
in our sample, which may also lead to reduced exercise 
capacity and ADL limitation.
Besides reflecting the level of physical activity and the 
ability to perform ADL, mobility was shown to be associated 
with dyspnea, which is considered the main symptom leading 
to limited exercise among COPD patients, often causing 
inactivity and deconditioning of peripheral muscles.53 
In another study, a strong association between limited ADL, 
as assessed through the London Chest Activity of Daily 
Living scale, and the degree of dyspnea, measured through the 
Medical Research Council scale, was observed.54 Weakness 
of skeletal muscles in COPD patients can be attributed to 
isolated or combined effects of deconditioning induced by 
inactivity, systemic inflammation, oxidative stress, smoking, 
aging, low levels of anabolic hormones, nutritional impair-
ment and use of corticosteroids.47 According to our results, 
this weakness interferes with the ability to attend places in 
the neighborhood with independence. This interference has 
been reported in another study with COPD patients. The study 
showed that weakness of the quadriceps was associated with 
reduced level of daily physical activity.55
Accelerometry provides accurate, individualized and 
detailed information on body movement, especially among 
individuals with typical slow gait, such as older adults with 
COPD.14 Other authors who have used accelerometers to 
assess the level of physical activity among COPD patients 
have shown that the active time of these patients is correlated 
with the quadriceps strength.56 Similar results were observed 
in our study; there was a slight correlation between life-space 
mobility, physical activity and peripheral muscle strength 
among young-old adults with COPD. Therefore, we believe 
that the evaluation of life-space mobility is appropriate to 
provide information not just on mobility but also on the level 
of physical activity of young-old adults with COPD.
Systemic effects of COPD such as dyspnea and fatigue can 
lead to decreased exercise tolerance, favoring a vicious cycle 
that results in generalized muscle weakness, sedentarism and 
physical inactivaty.57 However, pulmonary rehabilitation 
programs can improve dyspnea, functional balance, muscle 
strength and exercise tolerance among COPD patients.58 
The University of Alabama at Birmingham Study of Aging 
Life-Space questionnaire showed good correlation with the 
accelerometer data in the present study. This shows that this 
questionnaire is an excellent tool to evaluate the benefits of 
pulmonary rehabilitation programs with regard to actual 
daily mobility instead of only considering the performance 






Total score, pts (min–max) 60 (22–90) 71 (43.5–110) 0.02
Other rooms in the house besides the sleeping room, pts (min–max) 8 (8–8) 8 (8–8) 0.72
areas outside the house, pts (min–max) 16 (16–16) 16 (16–16) 0.35
Places in the neighborhood, pts (min–max) 21 (12–24) 24 (18–24) 0.03
Places outside the neighborhood, pts (min–max) 16 (8–22) 16 (13–30) 0.53
Places outside the city, pts (min–max) 0 (0–10) 0 (0–10) 0.60
Notes: Data are presented as median (interquartile range 25%–75%); p-value of Mann–Whitney test; questions on five levels of spaces visited by the older adult in the 
4 weeks prior to the assessment, including the following items: life-space level, frequency and independence; total score ranges from 0 to 120; other rooms in the house 
besides the sleeping room (range from 0 to 8 points); areas outside the house (range from 0 to 16 points); places in the neighborhood (range from 0 to 24 points); places 
outside the neighborhood (range from 0 to 32 points); and places outside the city (range from 0 to 40 points).
Abbreviations: pts, points; min, minimum; max, maximum.
Table 4 Correlation between mobility and dyspnea severity, 
peripheral muscle strength and accelerometry variables of the 
COPD group
Accelerometry variables r p-value
Dyspnea severity 0.44 ,0.001
Peripheral strength 0.42 ,0.001
sedentarism, % of the time -0.24 0.13
light activities, % of the time 0.15 0.36
Moderate activities, % of the time 0.40 0.01
Vigorous activities, % of the time 0.19 0.23
MVPa, minutes 0.43 0.01
Daily steps 0.43 0.01
Note: p-value of the Pearson’s correlation test.
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capacity of these patients. Furthermore, this questionnaire 
can be used in future studies with other populations because 
it is an easily applied and interpreted tool.
A limitation of this study was a low number of patients 
with severe and very severe COPD, which may have under-
estimated the results for life-space mobility limitation. 
This may have occurred because we collected data from an 
outpatient clinic, which naturally requires patients to get 
out of their homes; we hypothesize that patients with severe 
and very severe COPD had life-space mobility limited to a 
point that they were not able to attend this clinic and thus 
were the minority in our sample. Also, we recognize that 
our sample is younger than that expected for older adults 
with COPD, but this can be a characteristic of patients 
with COPD in Brazil, as observed in previous studies.59,60 
Furthermore, patients were not questioned about the reasons 
that led them to not attend spaces, such as dyspnea, lack of 
motivation, architectural barriers, and financial conditions. 
This would allow the comparison of factors that influence 
decreased mobility among young-old adults with and without 
COPD. Another point should be the difference in the age of 
subjects considered elderly in our study and in the developed 
countries. The World Health Organization considers subjects 
over 60 years of age as elderly in developing countries, such 
as Brazil.29 However, this population with worse conditions 
of health and education should be similar to subjects with 
65 years from developed countries with the same disease 
severity. Therefore, our results may be generalizable to other 
countries. However, we believe that addressing this aspect 
would be important in future studies.
Conclusion
In conclusion, the results showed that life-space mobility 
is reduced in young-old adults with COPD when compared 
to older adults without lung illness, especially in relation to 
displacement within the neighborhood. We also observed that 
reduced life-space mobility is related to dyspnea severity, 
peripheral muscle weakness and reduced physical activity 
assessed by accelerometry.
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Table S1 UaB study of aging life-space assessment™
Name: Date:
These questions refer to your activities just within the past month.
Life-space level Frequency Independence Score
During the past four weeks, have you 
been to…
How often did you get there? Did you use aids or 
equipment?








Other rooms of your 
home besides the room 

























Score   X     X     =
Life-Space Level 2…
An area outside your 
home such as  
your porch, deck or  
patio, hallway (of an  
apartment building)  
or garage, in your own 

























Score   X     X     =
Life-Space Level 3…
Places in your 
neighborhood, other  


























Score   X     X     =
Life-Space Level 4…
Places outside your  


























Score   X     X     =
Life-Space Level 5…


























Score   X     X     =
Total score (add) 
 
Sum of Levels
Notes: reprinted from Peel C, sawyer Baker P, roth Dl, et al. assessing mobility in older adults: the UaB study of aging life-space assessment. Phys Ther. 2005;85(10): 
1008–1119; with permission of Oxford University Press.1
Abbreviation: UaB, University of alabama at Birmingham.
Reference
1. Peel C, Sawyer Baker P, Roth DL, et al. Assessing mobility in older adults: 
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